Figure 2
Reduced risk of myelosuppression after BFR conditioning for alloSCT. (A) Proportion of patients with normal platelet counts at study entry and who maintained a platelet count >20 × 109/L after transplantation. (B) Proportion of patients with normal ANC at study entry who maintained counts of 0.5 × 109/L after transplantation.
